Collegium Pharmaceutical, Inc. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their drugs on animals to assess a product’s safety profile.
The following report cites that the company uses animals for drug testing.
“The FDA will also require studies specific to Xtampza, including- several long-term animal studies to evaluate the mixture of beeswax, carnauba wax, and myristic acid that is representative of Xtampza’s composition.” (Page 41) Read the full document.
Collegium Pharmaceutical, Inc. is a clinical-stage pharmaceutical company, which focuses on the development of proprietary, late stage pharmaceutical products. These products target market opportunities through formulation based product improvements protected by intellectual property. It builds a portfolio of pain products that incorporate its patent protected DETERx formulation platform that provides for extended release and tamper resistance. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Canton, MA. [Source: MarketWatch]
Company Website: http://www.collegiumpharma.com